CVE:NSCI Nanalysis Scientific (NSCI) Stock Price, News & Analysis C$0.24 +0.01 (+2.17%) As of 01:45 PM Eastern Add Compare Share Share Stock Analysis Stock AnalysisChartHeadlinesInsider TradesBuy This Stock About Nanalysis Scientific Stock (CVE:NSCI) 30 days 90 days 365 days Advanced Chart View Price History Chart DataSkip Price History Chart Get Nanalysis Scientific alerts:Sign Up Key Stats Today's RangeC$0.23▼C$0.2450-Day RangeC$0.23▼C$0.3052-Week RangeC$0.23▼C$0.46Volume145,833 shsAverage Volume79,229 shsMarket CapitalizationC$26.57 millionP/E RatioN/ADividend YieldN/APrice TargetN/AConsensus RatingN/A Company Overview Nanalysis Scientific Corp. engages in the development, manufacture, and sale of magnetic resonance products in the United States, Canada, Europe, Asia, and internationally. The company operates through four segments: Nanalysis, RS2D, K'Prime, and Corporate. It offers nuclear magnetic resonance (NMR) spectrometers; software module packages; cutting-edge electronics components for precision analytical instruments; and services for its NMR technologies. It serves pharmaceutical, security, biotech, nutraceutical, chemical, food, materials, medical, and education industries. The company is headquartered in Calgary, Canada. Read More Receive NSCI Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Nanalysis Scientific and its competitors with MarketBeat's FREE daily newsletter. Email Address NSCI Stock News HeadlinesNanalysis Announces First Regulated Assay for ... - MorningstarJuly 11, 2025 | morningstar.comMNanalysis Scientific Closes $2 Million Note OfferingJune 13, 2025 | tipranks.comI was wrong about TrumpI made a mistake. A mistake I feel very foolish about. After speaking with Donald Trump and some of his advisors, I believed him. I believed the promise that he would finally confront the single most dangerous threat to American life. That he would fix the ticking time bomb I’ve been warning about for 15 years. But I was wrong.July 18 at 2:00 AM | Porter & Company (Ad)Nanalysis Announces Fully Subscribed $2 Million Note OfferingJune 7, 2025 | finance.yahoo.comNanalysis Scientific Corp.: Nanalysis Announces First Quarter 2025 ResultsMay 29, 2025 | finanznachrichten.deNanalysis Scientific Corp. (NSCIF) Q1 2025 Earnings Call TranscriptMay 28, 2025 | seekingalpha.comNanalysis Announces First Quarter 2025 Conference CallMay 15, 2025 | uk.finance.yahoo.comNanalysis Scientific Corp.: Nanalysis Announces Fourth Quarter and Full Year 2024 ResultsMay 3, 2025 | finanznachrichten.deSee More Headlines NSCI Stock Analysis - Frequently Asked Questions How have NSCI shares performed this year? Nanalysis Scientific's stock was trading at C$0.32 at the beginning of 2025. Since then, NSCI stock has decreased by 26.6% and is now trading at C$0.24. How do I buy shares of Nanalysis Scientific? Shares of NSCI stock and other Canadian stocks can be purchased through an online brokerage account. Popular online brokerages with access to the Canadian stock market include BMO InvestorLine, CIBC Investor's Edge, Desjardins Online Brokerage, HSBC InvestDirect, Laurentian Bank Discount Brokerage, National Bank Direct Brokerage, Qtrade Investor, Questrade, RBC Direct Investing, Scotia iTrade, TD Direct Investing, and Virtual Brokers. What other stocks do shareholders of Nanalysis Scientific own? Based on aggregate information from My MarketBeat watchlists, some other companies that Nanalysis Scientific investors own include Lightwave Logic (LWLG), Air Canada (AC), CloudMD Software & Services (DOC), NioCorp Developments (NIOBF), Tilray Brands (TLRY), Achieve Life Sciences (ACHV) and Alamos Gold (AGI). Industry, Sector and Symbol Stock ExchangeCVE SectorComputer and Technology Industry Scientific & Technical Instruments Sub-IndustryN/A Current SymbolCVE:NSCI CIKN/A Webwww.nanalysis.com Phone403-769-9499FaxN/AEmployees249Year FoundedN/AProfitability EPS (Trailing Twelve Months)C($0.12) Trailing P/E RatioN/A Forward P/E Ratio12.93 P/E GrowthN/ANet Income-C$12.93 million Net Margins-32.75% Pretax MarginN/A Return on Equity-38.02% Return on Assets-7.55% Debt Debt-to-Equity Ratio71.72 Current Ratio1.42 Quick Ratio1.11 Sales & Book Value Annual SalesC$39.47 million Price / Sales0.67 Cash FlowC$0.03 per share Price / Cash Flow8.93 Book ValueC$0.21 per share Price / Book1.12Miscellaneous Outstanding Shares113,060,000Free FloatN/AMarket CapC$26.57 million OptionableNot Optionable Beta0.72 A Beginner's Guide to Investing in CannabisUnlock your free copy of MarketBeat's comprehensive guide to pot stock investing and discover which cannabis companies are poised for growth. Plus, you'll get exclusive access to our daily newsletter with expert stock recommendations from Wall Street's top analysts.Get This Free Report This page (CVE:NSCI) was last updated on 7/18/2025 by MarketBeat.com Staff From Our PartnersI warned you about Nvidia… now look what’s happeningNvidia just got Trump’s greenlight to sell high-powered AI chips to China — and their stock surged 5% before t...Timothy Sykes | SponsoredYour Bank Account Is No Longer SafeWhat If Washington Declared That: YOUR Money ISN'T Actually Yours? Sounds insane, but that's exactly what ...Priority Gold | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredThe End of Elon Musk…?The End of Elon Musk? Don't make him laugh. Jeff Brown has been hearing this same tired story for years, an...Brownstone Research | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredTurn $1K into $50K with This DeFi GemI've never been more confident about a DeFi opportunity. This isn't about complex trading or risky bets. Th...Crypto 101 Media | SponsoredWill I be blacklisted?Porter Stansberry says a financial force bigger than 9/11 or COVID is already ripping through America — and mo...Porter & Company | Sponsored“All the land that you see I will give to you and your offspring forever…”“This land I will give to you…” — a 4,000-year-old line from Genesis may hold the key to unlocking a $150 tril...Paradigm Press | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Nanalysis Scientific Corp. Please log in to your account or sign up in order to add this asset to your watchlist. Share Nanalysis Scientific With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.